139 related articles for article (PubMed ID: 37011832)
61. Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.
Nihira NT; Ogura K; Shimizu K; North BJ; Zhang J; Gao D; Inuzuka H; Wei W
Sci Signal; 2017 Feb; 10(466):. PubMed ID: 28196907
[TBL] [Abstract][Full Text] [Related]
62. ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation.
Meulmeester E; Pereg Y; Shiloh Y; Jochemsen AG
Cell Cycle; 2005 Sep; 4(9):1166-70. PubMed ID: 16082221
[TBL] [Abstract][Full Text] [Related]
63. O-GlcNAc transferase regulates p21 protein levels and cell proliferation through the FoxM1-Skp2 axis in a p53-independent manner.
de Queiroz RM; Moon SH; Prives C
J Biol Chem; 2022 Sep; 298(9):102289. PubMed ID: 35868563
[TBL] [Abstract][Full Text] [Related]
64. Functional analysis and consequences of Mdm2 E3 ligase inhibition in human tumor cells.
Wade M; Li YC; Matani AS; Braun SM; Milanesi F; Rodewald LW; Wahl GM
Oncogene; 2012 Nov; 31(45):4789-97. PubMed ID: 22266850
[TBL] [Abstract][Full Text] [Related]
65. p53 Ubiquitination Comediated by HUWE1 and TRAF6 Contributes to White Spot Syndrome Virus Infection in Crustacean.
Gong Y; Kong T; Aweya JJ; Ma H; Zhang Y; Li S
J Virol; 2022 Mar; 96(6):e0202921. PubMed ID: 35107378
[TBL] [Abstract][Full Text] [Related]
66. BCAS3 exhibits oncogenic properties by promoting CRL4A-mediated ubiquitination of p53 in breast cancer.
Zhou Z; Qiu R; Liu W; Yang T; Li G; Huang W; Teng X; Yang Y; Yu H; Yang Y; Wang Y
Cell Prolif; 2021 Aug; 54(8):e13088. PubMed ID: 34240781
[TBL] [Abstract][Full Text] [Related]
67. The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a.
Sparks A; Dayal S; Das J; Robertson P; Menendez S; Saville MK
Oncogene; 2014 Sep; 33(38):4685-96. PubMed ID: 24121268
[TBL] [Abstract][Full Text] [Related]
68. Mutant p53 Sequestration of the MDM2 Acidic Domain Inhibits E3 Ligase Activity.
Yang L; Song T; Cheng Q; Chen L; Chen J
Mol Cell Biol; 2019 Feb; 39(4):. PubMed ID: 30455251
[TBL] [Abstract][Full Text] [Related]
69. MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradation.
Fu W; Ma Q; Chen L; Li P; Zhang M; Ramamoorthy S; Nawaz Z; Shimojima T; Wang H; Yang Y; Shen Z; Zhang Y; Zhang X; Nicosia SV; Zhang Y; Pledger JW; Chen J; Bai W
J Biol Chem; 2009 May; 284(21):13987-4000. PubMed ID: 19321440
[TBL] [Abstract][Full Text] [Related]
70. PCAF ubiquitin ligase activity inhibits Hedgehog/Gli1 signaling in p53-dependent response to genotoxic stress.
Mazzà D; Infante P; Colicchia V; Greco A; Alfonsi R; Siler M; Antonucci L; Po A; De Smaele E; Ferretti E; Capalbo C; Bellavia D; Canettieri G; Giannini G; Screpanti I; Gulino A; Di Marcotullio L
Cell Death Differ; 2013 Dec; 20(12):1688-97. PubMed ID: 24013724
[TBL] [Abstract][Full Text] [Related]
71. The p73 tumor suppressor is targeted by Pirh2 RING finger E3 ubiquitin ligase for the proteasome-dependent degradation.
Jung YS; Qian Y; Chen X
J Biol Chem; 2011 Oct; 286(41):35388-35395. PubMed ID: 21852228
[TBL] [Abstract][Full Text] [Related]
72. UBXN2A enhances CHIP-mediated proteasomal degradation of oncoprotein mortalin-2 in cancer cells.
Sane S; Hafner A; Srinivasan R; Masood D; Slunecka JL; Noldner CJ; Hanson AD; Kruisselbrink T; Wang X; Wang Y; Yin J; Rezvani K
Mol Oncol; 2018 Oct; 12(10):1753-1777. PubMed ID: 30107089
[TBL] [Abstract][Full Text] [Related]
73. Regulation of the p53 Family Proteins by the Ubiquitin Proteasomal Pathway.
Bang S; Kaur S; Kurokawa M
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905981
[TBL] [Abstract][Full Text] [Related]
74. RNF125 is a ubiquitin-protein ligase that promotes p53 degradation.
Yang L; Zhou B; Li X; Lu Z; Li W; Huo X; Miao Z
Cell Physiol Biochem; 2015; 35(1):237-45. PubMed ID: 25591766
[TBL] [Abstract][Full Text] [Related]
75. DCAF13 promotes breast cancer cell proliferation by ubiquitin inhibiting PERP expression.
Shan BQ; Wang XM; Zheng L; Han Y; Gao J; Lv MD; Zhang Y; Liu YX; Zhang H; Chen HS; Ao L; Zhang YL; Lu X; Wu ZJ; Xu Y; Che X; Heger M; Cheng SQ; Pan WW; Zhang X
Cancer Sci; 2022 May; 113(5):1587-1600. PubMed ID: 35178836
[TBL] [Abstract][Full Text] [Related]
76. The ubiquitin ligase LIN41/TRIM71 targets p53 to antagonize cell death and differentiation pathways during stem cell differentiation.
Nguyen DTT; Richter D; Michel G; Mitschka S; Kolanus W; Cuevas E; Wulczyn FG
Cell Death Differ; 2017 Jun; 24(6):1063-1078. PubMed ID: 28430184
[TBL] [Abstract][Full Text] [Related]
77. YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress.
Grönroos E; Terentiev AA; Punga T; Ericsson J
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12165-70. PubMed ID: 15295102
[TBL] [Abstract][Full Text] [Related]
78. The p53 paddy wagon: COP1, Pirh2 and MDM2 are found resisting apoptosis and growth arrest.
Corcoran CA; Huang Y; Sheikh MS
Cancer Biol Ther; 2004 Aug; 3(8):721-5. PubMed ID: 15280670
[TBL] [Abstract][Full Text] [Related]
79. Proposal for a role of the Hsp90/Hsp70-based chaperone machinery in making triage decisions when proteins undergo oxidative and toxic damage.
Pratt WB; Morishima Y; Peng HM; Osawa Y
Exp Biol Med (Maywood); 2010 Mar; 235(3):278-89. PubMed ID: 20404045
[TBL] [Abstract][Full Text] [Related]
80. RING finger protein 31 promotes p53 degradation in breast cancer cells.
Zhu J; Zhao C; Zhuang T; Jonsson P; Sinha I; Williams C; Strömblad S; Dahlman-Wright K
Oncogene; 2016 Apr; 35(15):1955-64. PubMed ID: 26148235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]